BioSpace News Archive

Press Releases

INmune Bio Advances Ebstrocel™ Toward European Marketing Authorization with EMA Regulatory Filings

August 26, 2026
·
7 min read
Press Releases

Vivace Therapeutics Strengthens Leadership Team as It Prepares to Advance VT3989, the First TEAD Inhibitor to enter Phase 3 Clinical Trials, as the Leading Treatment for Mesothelioma

August 26, 2026
·
7 min read
Press Releases

HaemaLogiX Announces Major Milestone with First Patient Successfully Dosed with KMCAR™ T-Cell

August 26, 2026
·
6 min read
Press Releases

Alebund Pharmaceuticals Announces 2026 Interim Results

August 26, 2026
·
20 min read
Press Releases

Zepbound linked to lower healthcare costs in adults over age 55 with obesity according to a real-world study

August 26, 2026
·
14 min read
Press Releases

Insulet to Participate in Wells Fargo 21st Annual Healthcare Conference

August 26, 2026
·
1 min read
Press Releases

Definium Therapeutics to Participate at Upcoming Investor Conferences and Events

August 26, 2026
·
2 min read
Press Releases

TROPION-Urothelial04 Phase 3 Trial of Datroway® Initiated as Adjuvant Therapy in Patients with High-Risk Muscle Invasive Urothelial Cancer

August 26, 2026
·
19 min read
Press Releases

Eikon Therapeutics to Participate in Investor Conferences in September 2026

August 26, 2026
·
3 min read
Press Releases

BridgeBio Announces First Participant Dosed in ASCEND-ATTR, a Phase 3b/4 Study Evaluating the Long-Term Effects of Acoramidis on Disease Regression in ATTR-CM

August 26, 2026
·
8 min read